메뉴 건너뛰기




Volumn 44, Issue 2, 2014, Pages e5-e6

Flare of calcinosis despite rituximab therapy

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

EID: 84927573866     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.04.007     Document Type: Editorial
Times cited : (16)

References (4)
  • 1
    • 84861224387 scopus 로고    scopus 로고
    • Treatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature
    • Daoussis D., Antonopoulos I., Liossis S.N., Yiannopoulos G., Andonopoulos A. Treatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature. Semin Arthritis Rheum 2012, 41:822-829.
    • (2012) Semin Arthritis Rheum , vol.41 , pp. 822-829
    • Daoussis, D.1    Antonopoulos, I.2    Liossis, S.N.3    Yiannopoulos, G.4    Andonopoulos, A.5
  • 3
    • 85027911427 scopus 로고    scopus 로고
    • Extended report: effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
    • on behalf of the EUSTAR Rituximab study group, [Epub ahead of print]
    • Jordan S., Distler J.H., Maurer B., Huscher D., van Laar J.M., Allanore Y., et al. Extended report: effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheum Dis 2014, on behalf of the EUSTAR Rituximab study group, [Epub ahead of print].
    • (2014) Ann Rheum Dis
    • Jordan, S.1    Distler, J.H.2    Maurer, B.3    Huscher, D.4    van Laar, J.M.5    Allanore, Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.